FORMULATION Russian patent published in 2012 - IPC A61K9/00 

Abstract RU 2470628 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: group of inventions refers to stable, aqueous pharmaceutical composition containing an antibody having a heavy chain with amino acid sequence SEQ ID No: 3 and a light chain with amino acid sequence SEQ ID No: 4, and a pharmaceutically acceptable adjuvant, solvent, carrier or excipient wherein said composition has pH 4 to 6 and methods for using it for treating atherosclerosis and atherosclerosis-associated diseases.

EFFECT: group of inventions is characterised by high stability; it is effective in treating atherosclerosis.

52 cl, 2 tbl, 5 ex, 2 dwg

Similar patents RU2470628C2

Title Year Author Number
IMMUNOTHERAPEUTIC TREATMENT 2006
  • Karlsson Roland
  • Nil'Sson Jan
RU2454428C2
USE OF PEPTIDE FOR TREATMENT OF CARDIOVASCULAR DISEASES 2013
  • Gibot Sebastien
  • Boufenzer Amir
  • Alt-Oufella Hafid
  • Derive Marc
RU2672341C2
PEPTIDE FRAGMENTS, PHARMACEUTICAL COMPOSITIONS AND VACCINES BASED ON THE SAME, AND USES THEREOF IN PROPHYLAXIS AND THERAPY OF ARTERIOSCLEROSIS 2002
  • Nil'Sson Jan
  • Shakh Prediman K.
RU2296582C2
COMPOSITIONS WHICH POISSESS LIPID-REDUCING PROPERTIES 2006
  • Vest Sajmon Majkl
  • Ogru Ehsra
  • Libinaki Roksan
RU2428973C2
USE OF 2,4-DIAMINOPYRIMIDINES FOR TREATING ATHEROSCLEROSIS 2009
  • Masuda Ehsteban
  • Shmitts Jokhen
RU2490015C2
APPLICATION FOR TREATING AND PREVENTING ATHEROSCLEROSIS OF PROTEIN-PEPTIDE COMPLEX (HEREINAFTER PPC) OBTAINED FROM EMBRYONIC NERVE TISSUE OR OF QUICK FROZEN EMBRYO BRAIN OF FARM HOOFED ANIMALS AFFECTING CHECK TRANSPORT CHOLESTEROL FROM VASCULAR WALL AND PROFILE OF ACTIVATION OF MONOCYTES IN PATIENTS WITH MANIFESTED ATHEROSCLEROSIS OF GREAT VESSELS OR WITH PREDISPOSITION TO CARDIOVASCULAR DISEASES AND METHOD FOR PREVENTING AND TREATING PATIENTS WITH ARTERIAL ATHEROSCLEROSIS AND DISEASES CAUSED BY ATHEROSCLEROSIS OF MAJOR AND PERIPHERAL VASCULAR CEREBRAL, HEART, AORTA AND LOWER EXTREMITIES (TWO VERSIONS) 2014
  • Nazarenko Anna Borisovna
RU2586286C2
PEPTIDE POSSESSING ABILITY TO RELIEVE AT LEAST ONE SYMPTOM OF INFLAMMATORY CONDITION, PHARMACEUTICAL COMPOSITION CONTAINING IT AND METHOD OF TREATING ATHEROSCLEROSIS WITH THEIR APPLICATION 2005
  • Anantkharamajakh Gattadakhalli M.
  • Navab Mokhamad
  • Fogelmehn Ehlan M.
RU2448977C2
METHODS FOR IDENTIFYING AND PREDICTING RISK OF CARDIOVASCULAR EVENT OR DISEASE OR FATAL OUTCOME, METHODS FOR ASSESSING SEVERITY AND MONITORING OF CARDIOVASCULAR EVENT OR DISEASE, METHOD FOR MONITORING EFFECTIVENESS OF THERAPY 2014
  • Derive Marc
  • Gibot Sebastien
  • Ait-Oufella Hafid
  • Boufenzer Amir
  • Simon Tabasomme
  • Danchin Nicolas
RU2721690C2
4-FLUORO-N-INDANE-2-YLBENZAMIDE AND ITS USING AS PHARMACEUTICAL AGENT 2002
  • Vol'Fart Paulus
  • Suzuki Teri
  • Dkharanipragada Ramalinga M.
  • Safarova Alena
  • Val'Zer Armin
  • Shtrobel' Khartmut
RU2308946C2
METHOD OF INHIBITION AND PROPHYLAXIS OF VASCULAR SYMPTOMS RISING BY BETA-CAROTENE AND VITAMIN E, A PHARMACEUTICAL COMPOSITION CONSISTING OF BETA-CAROTENE AND VITAMIN E, A PHARMACEUTICAL COMPOSITION CONSISTING OF BETA-CAROTENE AND ASPIRIN 1991
  • Charlz Kh.Khennekens
RU2126679C1

RU 2 470 628 C2

Authors

Nil'Sson Fredrik

Brink Karl Jokhan

Dates

2012-12-27Published

2008-12-22Filed